Certuity’s Immix Biopharma IMMX Stock Holding History

Certuity’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$364K	Hold	35,000	–	–	0.02%	476
2026 Q2	$361K	Hold	35,000	–	–	0.02%	455
2026 Q1	$319K	Buy	+35,000	New	+$257K	0.02%	428

Other funds holding IMMX

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Compass Financial Management Tampa, Florida $926M AUM

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Certuity's IMMX Position: Q3 2026 in Review

Certuity held its Immix Biopharma (IMMX) position steady in Q3 2026 at 35,000 shares worth $364K. The position accounts for 0.02% of the portfolio, ranked #476.

Certuity first reported a position in IMMX in Q1 2026 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

Certuity held 35,000 shares of Immix Biopharma worth $364K as of Q3 2026.
Certuity left its Immix Biopharma share count unchanged in Q3 2026.
Immix Biopharma made up 0.02% of Certuity's portfolio in Q3 2026, its #476 holding.
Certuity first reported a position in Immix Biopharma in Q1 2026 and has held it in 3 quarters since.
20 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Certuity's 13F filing for Q3 2026, filed 2 Nov 2026.